MORGAN STANLEY PLC/CALL/MERCK & CO./165/0.1/20.06.25 Share Price

Warrant

DE000ME8HEF8

Market Closed - Bid/Ask 17:49:24 17/05/2024 BST After market 20:01:29
0.233 EUR -3.32% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./165/0.1/20.06.25 0.236 +1.29%
Current month-10.74%
1 month-3.60%
Date Price Change
17/05/24 0.233 -3.32%
16/05/24 0.241 +4.33%
15/05/24 0.231 +13.79%
14/05/24 0.203 -0.98%
13/05/24 0.205 -16.33%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 05:49 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN ME8HEF
ISINDE000ME8HEF8
Date issued 09/02/2024
Strike 165 $
Maturity 20/06/2025 (399 Days)
Parity 10 : 1
Emission price 0.25
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.38
Lowest since issue 0.19
Spread 0.004
Spread %1.68%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.9 USD
Average target price
141.6 USD
Spread / Average Target
+8.22%
Consensus